Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 110 entries
View as:

A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT02866747 Org: User:
Start: 01/17/17 End: 11/02/24 Due: 11/02/25

Study of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT06222138 Org: User:
Start: 08/27/24 End: 05/31/28 Due: 05/31/29

A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa.

Phase: N/A Priority: Normal
NCT ID: NCT06022159 Org: User:
Start: 11/28/23 End: 05/31/29 Due: 05/31/30

Cost Utility of Radical Surgery in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02854215 Org: User:
Start: 01/18/17 End: 04/15/25 Due: 04/15/26

Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance

Phase: N/A Priority: Normal
NCT ID: NCT04821336 Org: User:
Start: 04/15/21 End: 12/31/22 Due: 12/31/23

CINSARC Genomic Signature as Predictor of Resectability of Ovarian Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04248231 Org: User:
Start: 09/15/19 End: 12/23/21 Due: 12/23/22

Male breAsT cAncer preDisposition Factor

Phase: N/A Priority: Normal
NCT ID: NCT06219187 Org: User:
Start: 02/08/24 End: 02/06/25 Due: 02/06/26

Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

Phase: N/A Priority: Normal
NCT ID: NCT04940000 Org: User:
Start: 09/02/21 End: 09/30/28 Due: 09/30/29

Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06904625 Org: User:
Start: 04/30/25 End: 01/31/26 Due: 01/31/27

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00695032 Org: User:
Start: 10/31/07 End: - Due: -

Role of Surgery in Advanced Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03980028 Org: User:
Start: 01/01/18 End: 06/01/19 Due: 06/01/20

Acceptability and Benefits of an Onco-sexology Program for Laryngectomy Patients and Their Partners

Phase: N/A Priority: Normal
NCT ID: NCT06517355 Org: User:
Start: 07/30/24 End: 03/31/28 Due: 03/31/29

A Trial Evaluating Stereotactic Radiotherapy Plus Durvalumab Continuation for Patients With NSCLC Metachronous Oligometastatic Disease Under Durvalumab Consolidation Following Chemoradiation

Phase: N/A Priority: Normal
NCT ID: NCT03955198 Org: User:
Start: 05/27/21 End: 08/26/24 Due: 08/26/25

Optimization of the Patient Care Pathway in Immuno-oncology

Phase: N/A Priority: Normal
NCT ID: NCT03329755 Org: User:
Start: 12/26/17 End: 02/19/21 Due: 02/19/22

Prospective, Multicentric Study Evaluating the Surgical Treatment by Mastectomy With Immediate Prosthetic Breast Reconstruction in Patients With Breast Cancer and Receiving Adjuvant Therapy by TomoTherapy +/-Chemotherapy.

Phase: N/A Priority: Normal
NCT ID: NCT03627988 Org: User:
Start: 06/07/19 End: 05/31/26 Due: 05/31/27

Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03953352 Org: User:
Start: 08/31/19 End: 01/31/21 Due: 01/31/22

Cisplatin or ImmunoTHerapy in Association With Definitive Radiotherapy in HPV-related oropharyngEal Squamous Cell Carcinoma: a Randomized Phase II Trial.

Phase: N/A Priority: Normal
NCT ID: NCT03623646 Org: User:
Start: 03/15/19 End: 02/14/23 Due: 02/14/24

Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mm

Phase: N/A Priority: Normal
NCT ID: NCT02266420 Org: User:
Start: 10/23/14 End: 10/29/24 Due: 10/29/25

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no More Than Three Residual Metastatic Lesions Following First Line Systemic Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04428554 Org: User:
Start: 06/30/20 End: 07/31/28 Due: 07/31/29

Cilengitide Together With Radiochemotherapy in Patients With Locally Advanced Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01118676 Org: User:
Start: 03/31/10 End: 04/30/15 Due: 04/30/16

Circulating miRNAs as Biomarkers of Hormone Sensitivity in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01612871 Org: User:
Start: 06/27/12 End: 01/28/16 Due: 01/28/17

Blocking TNF to Potentiate the ICI-dependent Immune Awakening in Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05867004 Org: User:
Start: 01/01/23 End: 12/31/26 Due: 12/31/27

Chronic Pain and Minor Breast Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03912948 Org: User:
Start: 04/01/19 End: 12/31/19 Due: 12/31/20

Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae

Phase: N/A Priority: Normal
NCT ID: NCT05757817 Org: User:
Start: 11/08/23 End: 01/31/27 Due: 01/31/28

Observation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00870701 Org: User:
Start: 03/19/09 End: 03/10/17 Due: 03/10/18